- Home
- ANTE vs GNPX Comparison
ANTE vs GNPX Comparison
Compare ANTE & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTE
- GNPX
- Stock Information
- Founded
- ANTE 2005
- GNPX 2009
- Country
- ANTE China
- GNPX United States
- Employees
- ANTE N/A
- GNPX N/A
- Industry
- ANTE Advertising
- GNPX Biotechnology: Pharmaceutical Preparations
- Sector
- ANTE Consumer Discretionary
- GNPX Health Care
- Exchange
- ANTE Nasdaq
- GNPX Nasdaq
- Market Cap
- ANTE 6.7M
- GNPX 6.1M
- IPO Year
- ANTE N/A
- GNPX 2018
- Fundamental
- Price
- ANTE $0.45
- GNPX $0.75
- Analyst Decision
- ANTE
- GNPX Strong Buy
- Analyst Count
- ANTE 0
- GNPX 1
- Target Price
- ANTE N/A
- GNPX $10.00
- AVG Volume (30 Days)
- ANTE 50.9K
- GNPX 367.1K
- Earning Date
- ANTE 09-30-2024
- GNPX 11-13-2024
- Dividend Yield
- ANTE N/A
- GNPX N/A
- EPS Growth
- ANTE N/A
- GNPX N/A
- EPS
- ANTE 2.64
- GNPX N/A
- Revenue
- ANTE $500,000.00
- GNPX N/A
- Revenue This Year
- ANTE N/A
- GNPX N/A
- Revenue Next Year
- ANTE N/A
- GNPX N/A
- P/E Ratio
- ANTE $0.17
- GNPX N/A
- Revenue Growth
- ANTE N/A
- GNPX N/A
- 52 Week Low
- ANTE $0.26
- GNPX $0.28
- 52 Week High
- ANTE $2.90
- GNPX $13.00
- Technical
- Relative Strength Index (RSI)
- ANTE 49.49
- GNPX 40.74
- Support Level
- ANTE $0.42
- GNPX $0.66
- Resistance Level
- ANTE $0.47
- GNPX $0.74
- Average True Range (ATR)
- ANTE 0.04
- GNPX 0.06
- MACD
- ANTE 0.00
- GNPX 0.00
- Stochastic Oscillator
- ANTE 41.25
- GNPX 35.04
About ANTE AirNet Technology Inc.
AirNet Technology Inc provides in-flight solutions to connectivity, entertainment, and digital multimedia in China. It offers Internet connections through a network of satellites and land-based beacons, provides airline travelers with interactive entertainment, and breaking news, and furnishes corporate clients with advertisements tailored to the perceptions of the travelers. The revenues are mainly derived from selling advertising time slots on the companies advertising networks and cryptocurrency mining.
About GNPX Genprex Inc.
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's lead product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.